A case report published in the journal Australasian Psychiatry has determined the standardized cannabinoid extract Sativex is both safe and effective at mitigating symptoms of Tourette syndrome. Investigators at the Tauranga Hospital, Department of Psychiatry in New Zealand administered Sativex, which is a spray with equal parts THC to CBD, twice a day to a patient with treatment resistant Tourette syndrome. They found the patient's motor tics reduced by 85 percent and vocal tics reduced by 90 percent. Authors said, "Our results support previous research suggesting that cannabinoids are a safe and effective treatment for TS and should be considered in treatment-resistant cases.”
This information has been provided by the Daily Chronic and approved by our Chief Medical Officer.